Vaccination is essential for patients with paroxysmal nocturnal hemoglobinuria (PNH) prior to receiving treatments like eculizumab and iptacocan, as these medications increase the risk of vaccine-preventable diseases. Specifically, meningococcal vaccines are mandated due to the heightened risk of meningococcal disease in individuals receiving complement inhibitor therapy.
